P1052: A REAL-WORLD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS

• Minghui Duan,
• Lan MA,
• Qiuling Wu,
• Hong Liang,
• Wei Wang,
• Shaoling Wu,
• Lijun Mu,
• Hai Lin,
• Hebing Zhou,
• Hongxia Shi,
• Hongmei Jing

Affiliations

Minghui Duan

1 Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Hematology, Beijing, China

Lan MA

2 Peking University Third Hospital, Beijing, China

Qiuling Wu

3 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Hong Liang

4 Clinical Research Center for Hematologic Disease, Harbin, China

Wei Wang

5 Department of Hematology,The Hospital of Qingdao University, Qingdao, China

Shaoling Wu

5 Department of Hematology,The Hospital of Qingdao University, Qingdao, China

Lijun Mu

6 The Second Hospital of Dalian Medical University, Dalian, China

Hai Lin

7 First Hospital Affiliated of Jilin University, Jilin, China

Hebing Zhou

8 Beijing Luhe Hospital,Capital Medical University, Beijing, China

Hongxia Shi

9 National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Beijing, China

Hongmei Jing

2 Peking University Third Hospital, Beijing, China